v3.25.3
Debt, Cash and Cash Equivalents - Summary of Net Debt by Type Valuation of Redemption (Details) - EUR (€)
€ in Millions
Jun. 30, 2025
Dec. 31, 2024
Jun. 30, 2024
 [2]
Dec. 31, 2023
 [2]
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Interest rate and currency derivatives used to manage debt € 10 € 137    
Total debt 20,519 16,137    
Cash and cash equivalents [1] (15,359) (7,441) € (6,795) € (8,710)
Interest rate and currency derivatives used to manage cash and cash equivalents (58) 76    
Net debt [3] 5,102 8,772    
Value on redemption        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Bond issues 15,581 14,592    
Other bank borrowings 4,905 1,354    
Other borrowings 1 3    
Bank credit balances 141 209    
Interest rate and currency derivatives used to manage debt (68) 13    
Total debt 20,560 16,171    
Cash and cash equivalents (15,359) (7,441)    
Interest rate and currency derivatives used to manage cash and cash equivalents (58) 76    
Net debt [3] 5,143 8,806    
Value on redemption | non-current        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Cash and cash equivalents 0 0    
Interest rate and currency derivatives used to manage cash and cash equivalents 0 0    
Net debt 13,317 11,940    
Value on redemption | current        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Cash and cash equivalents (15,359) (7,441)    
Interest rate and currency derivatives used to manage cash and cash equivalents (58) 76    
Net debt (8,174) (3,134)    
Value on redemption | non-current        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Bond issues 13,259 11,876    
Other bank borrowings 58 64    
Other borrowings 0 0    
Bank credit balances 0 0    
Interest rate and currency derivatives used to manage debt 0 0    
Total debt 13,317 11,940    
Value on redemption | current        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Bond issues 2,322 2,716    
Other bank borrowings 4,847 [4] 1,290    
Other borrowings 1 3    
Bank credit balances 141 209    
Interest rate and currency derivatives used to manage debt (68) 13    
Total debt 7,243 € 4,231    
Value on redemption | current | Commercial paper program in USA        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Other bank borrowings 4,535      
Value on redemption | current | Commercial paper program in France        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Other bank borrowings € 230      
[1] These unaudited condensed half year consolidated financial statements as of June 30, 2025 should be read in conjunction with Sanofi’s audited consolidated financial statements as of December 31, 2024.
[2] Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.
[3] Net debt does not include lease liabilities, which amounted to €1,776 million as of June 30, 2025 and €1,906 million as of December 31, 2024.
[4] As of June 30, 2025, current other bank borrowings include €4,535 million related to the US commercial paper program and €230 million related to the Negotiable European Commercial Paper program in France.